Day Of Fiber Research Articles

Microstructured Optical Fiber Made From Biodegradable and Biocompatible Poly(D,L-Lactic Acid) (PDLLA)

We have fabricated and characterized microstructured biodegradable and biocompatible polymer optical fibers using commercially available poly(D,L-lactic acid) (PDLLA). We first report on the preparation of the preforms by means of a novel technique based on transfer molding and on the fiber manufacturing using a regular heat-drawing process. We address the influence of the polymer processing on the decrease of the molar mass of PDLLA following the preform fabrication and the fiber optic drawing process. We investigate the in vitro degradation of the fabricated fibers in phosphate buffered saline (PBS) that reveals 21, 25 and 43% molar mass loss over a period of 105 days for fibers with diameters of 400, 200 and 100 μm, respectively. Cutback measurements return an attenuation coefficient as low as 0.065 dB/cm at 898 nm for a microstructured fiber with a diameter of 219 ± 27 μm. Due to immersion in PBS at 37 °C, the optical loss increases by 0.4 dB/cm at 950 nm after 6 h and by 0.8 dB/cm after 17 h.

214 12-Month Post Marketing Safety Surveillance Data of Chewable Inulin Fiber

INTRODUCTION: Most Americans consume only half of the daily fiber recommended by the National Academy of Medicine, which is 25 grams per day of fiber for women and 38 grams per day for men. Fiber has been shown to promote bowel regularity, lower cholesterol, control blood sugar, and maintain body weight. To fill the “fiber gap” many patients use fiber supplements. There is a perception that fiber supplementation can lead to bloating and excess gas production, among other adverse events. This study aimed to examine whether or not a pattern of adverse events was associated with chewable inulin fiber (CIF). METHODS: A call-in number for reporting adverse events (AEs) was provided on bottles of a specific brand of CIF. An independent call center with pharmacovigilance-trained health care personnel in accordance with the FDA and global regulatory guidelines on properly reporting AEs was retained to receive and record customer AEs. The AEs for this study were collected and processed from January 1, 2018 to December 31, 2018. RESULTS: An estimated 809,259 individual patients consumed CIF during the surveillance. An analysis of the data showed that there were no serious AEs reported. Additionally, the self-reporting rate of non-serious AEs was low, with only 23 non-serious events reported by 21 individuals; a rate of 2.8 per 100,000 users. The top reported, non-serious AEs were flatulence, diarrhea, and constipation; however, the rates for these were extremely low (4.9, 3.7, and 1.2 per million, respectively). Two events were reported that were classified as musculoskeletal and connective tissue disorders; however, these were considered to not be related, having no basis for biological plausibility. CONCLUSION: 12 months of monitoring real-world use of CIF in a population of over 800,000 patients demonstrates an extremely low rate of self-reported AEs. Contrary to conventional thinking, the rate of flatulence was remarkably low (4.9 per million users), and can most likely be considered statistical background noise. These data, combined with previous RCTs, indicates that CIF is a safe and effective option for fiber supplementation.

Biopersistence of Rock Wool in Lungs after Short-Term Inhalation in Rats

To evaluate the safety of rock wool (RW), an asbestos substitute, we examined the biopersistence of RW fibers in rat lungs based on the changes of fiber number and fiber size (length and diameter) by a nose-only inhalation exposure study. Twenty-four male Fischer 344 rats were exposed to RW fibers at a concentration of 30 mg/m3 continuously for 3 h daily for 5 consecutive days. Six rats each were sacrificed shortly and at 1, 2, and 4 wk after exposure, and their lung tissues were ashed by a low-temperature plasma asher. Then the fiber numbers and fiber sizes in lungs were determined using a phase-contrast microscope and computed image analyzer. During the study period, the arithmetic mean (SD) values of fiber and weight concentrations were 78.5 (35.7) fibers/cm3, and 29.9 (28.3) mg/m3, respectively. The fiber number in lungs 4 wk after exposure significantly decreased from the baseline value (shortly after exposure) (p < .05). The half-life of fibers calculated from the approximate curve was 28 days for all fibers and 16 days for fibers with L > 20 μ m, and the rate of decrease in fiber number was 46.3% at 4 wk after exposure (shortly-after group = 100%). Likewise, both length and diameter significantly decreased at 4 wk after exposure (p < .05), probably because fibers were phagosytosed and digested by alveolar macrophages, discharged to outside of the body by mucociliary movement, or dissolved by body fluid. It will be necessary in the future to further confirm the safety of RW fibers by assessing the biopersistence of fibers in the lungs and their pathological effects in our ongoing study performed in accordance with the guidelines established in the “Methods for Determination of Hazardous Properties for Human Health of Man Made Mineral Fibers” (EC protocol).

Nutrition: the need to define "optimal" intake as a basis for public policy decisions.

Much of the current chronic disease incidence, notably coronary artery disease and certain types of cancer, relates to nutritionally induced metabolic overload. The evidence for this conclusion is based on extensive analytical, descriptive, and metabolic epidemiological investigations as well as critical experimental studies in animals. Dietary assessments within homogenous populations, because of inherent measurement errors and similarities in eating habits, make only limited contributions to this issue. This communication makes recommendations as to an "optimal" diet, especially for fats and fibers, as a goal for effective disease prevention that is within our reach with the appropriate support of an informed public and a cooperative food industry. To facilitate effective public health action, the "optimal" diet is called the 25/25 diet, that is, 25% of calories as fat and 25 g per day of fiber.